GURUFOCUS.COM » STOCK LIST » Technology » Software » Hestia Insight Inc (OTCPK:HSTA) » Definitions » Capex-to-Revenue

Hestia Insight (Hestia Insight) Capex-to-Revenue : 0.00 (As of Feb. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Hestia Insight Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Hestia Insight's Capital Expenditure for the three months ended in Feb. 2024 was $0.00 Mil. Its Revenue for the three months ended in Feb. 2024 was $0.04 Mil.

Hence, Hestia Insight's Capex-to-Revenue for the three months ended in Feb. 2024 was 0.00.


Hestia Insight Capex-to-Revenue Historical Data

The historical data trend for Hestia Insight's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hestia Insight Capex-to-Revenue Chart

Hestia Insight Annual Data
Trend Nov22 Nov23
Capex-to-Revenue
12.07 -

Hestia Insight Quarterly Data
Feb22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
Capex-to-Revenue Get a 7-Day Free Trial 0.93 - - - -

Competitive Comparison of Hestia Insight's Capex-to-Revenue

For the Software - Application subindustry, Hestia Insight's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hestia Insight's Capex-to-Revenue Distribution in the Software Industry

For the Software industry and Technology sector, Hestia Insight's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hestia Insight's Capex-to-Revenue falls into.



Hestia Insight Capex-to-Revenue Calculation

Hestia Insight's Capex-to-Revenue for the fiscal year that ended in Nov. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.113
=0.00

Hestia Insight's Capex-to-Revenue for the quarter that ended in Feb. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.038
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hestia Insight  (OTCPK:HSTA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Hestia Insight Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hestia Insight's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hestia Insight (Hestia Insight) Business Description

Traded in Other Exchanges
N/A
Address
400 S. 4th Street, Suite 500, Las Vegas, NV, USA, 89101
Hestia Insight Inc provides strategic consulting and capital market advisory services for micro, small and medium-sized companies in the healthcare, biotech and fintech sectors. It also provides access to seed capital and mezzanine funding for qualified emerging companies in these industries. The firm derives all of its revenue from consulting services.